Zoetis Inc. Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest
Zoetis Inc. (ZTS) reported Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest of $2.00 million for the 6-month period ending 2016-07-03, per its 10-Q filed 2016-08-05.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest · last filed 2016-08-05
- 2016-07-03: Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest 6 month $2.00M.
| Period end | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest 6 month |
|---|---|
| 2016-07-03 | $2.00M 10-Q · filed 2016-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |